Global In-Vitro Cancer Diagnostics Market Size, Status and Forecast 2022
SKU ID : QYR-19597242 | Publishing Date : 25-Nov-2021 | No. of pages : 107
Detailed TOC of Global In-Vitro Cancer Diagnostics Market Size, Status and Forecast 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Instruments
1.2.3 Reagents and Kits
1.3 Market by Application
1.3.1 Global In-Vitro Cancer Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Laboratories
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Cancer Diagnostics Market Perspective (2016-2027)
2.2 In-Vitro Cancer Diagnostics Growth Trends by Regions
2.2.1 In-Vitro Cancer Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 In-Vitro Cancer Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 In-Vitro Cancer Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 In-Vitro Cancer Diagnostics Industry Dynamic
2.3.1 In-Vitro Cancer Diagnostics Market Trends
2.3.2 In-Vitro Cancer Diagnostics Market Drivers
2.3.3 In-Vitro Cancer Diagnostics Market Challenges
2.3.4 In-Vitro Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-Vitro Cancer Diagnostics Players by Revenue
3.1.1 Global Top In-Vitro Cancer Diagnostics Players by Revenue (2016-2021)
3.1.2 Global In-Vitro Cancer Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global In-Vitro Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by In-Vitro Cancer Diagnostics Revenue
3.4 Global In-Vitro Cancer Diagnostics Market Concentration Ratio
3.4.1 Global In-Vitro Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Cancer Diagnostics Revenue in 2020
3.5 In-Vitro Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players In-Vitro Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into In-Vitro Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Cancer Diagnostics Breakdown Data by Type
4.1 Global In-Vitro Cancer Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global In-Vitro Cancer Diagnostics Forecasted Market Size by Type (2022-2027)
5 In-Vitro Cancer Diagnostics Breakdown Data by Application
5.1 Global In-Vitro Cancer Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global In-Vitro Cancer Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America In-Vitro Cancer Diagnostics Market Size (2016-2027)
6.2 North America In-Vitro Cancer Diagnostics Market Size by Type
6.2.1 North America In-Vitro Cancer Diagnostics Market Size by Type (2016-2021)
6.2.2 North America In-Vitro Cancer Diagnostics Market Size by Type (2022-2027)
6.2.3 North America In-Vitro Cancer Diagnostics Market Size by Type (2016-2027)
6.3 North America In-Vitro Cancer Diagnostics Market Size by Application
6.3.1 North America In-Vitro Cancer Diagnostics Market Size by Application (2016-2021)
6.3.2 North America In-Vitro Cancer Diagnostics Market Size by Application (2022-2027)
6.3.3 North America In-Vitro Cancer Diagnostics Market Size by Application (2016-2027)
6.4 North America In-Vitro Cancer Diagnostics Market Size by Country
6.4.1 North America In-Vitro Cancer Diagnostics Market Size by Country (2016-2021)
6.4.2 North America In-Vitro Cancer Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe In-Vitro Cancer Diagnostics Market Size (2016-2027)
7.2 Europe In-Vitro Cancer Diagnostics Market Size by Type
7.2.1 Europe In-Vitro Cancer Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe In-Vitro Cancer Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe In-Vitro Cancer Diagnostics Market Size by Type (2016-2027)
7.3 Europe In-Vitro Cancer Diagnostics Market Size by Application
7.3.1 Europe In-Vitro Cancer Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe In-Vitro Cancer Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe In-Vitro Cancer Diagnostics Market Size by Application (2016-2027)
7.4 Europe In-Vitro Cancer Diagnostics Market Size by Country
7.4.1 Europe In-Vitro Cancer Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe In-Vitro Cancer Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Type
8.2.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Application
8.3.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region
8.4.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America In-Vitro Cancer Diagnostics Market Size (2016-2027)
9.2 Latin America In-Vitro Cancer Diagnostics Market Size by Type
9.2.1 Latin America In-Vitro Cancer Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America In-Vitro Cancer Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America In-Vitro Cancer Diagnostics Market Size by Type (2016-2027)
9.3 Latin America In-Vitro Cancer Diagnostics Market Size by Application
9.3.1 Latin America In-Vitro Cancer Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America In-Vitro Cancer Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America In-Vitro Cancer Diagnostics Market Size by Application (2016-2027)
9.4 Latin America In-Vitro Cancer Diagnostics Market Size by Country
9.4.1 Latin America In-Vitro Cancer Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America In-Vitro Cancer Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Cancer Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type
10.2.1 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application
10.3.1 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country
10.4.1 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 MDx Health Quest Diagnostics
11.1.1 MDx Health Quest Diagnostics Company Details
11.1.2 MDx Health Quest Diagnostics Business Overview
11.1.3 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Introduction
11.1.4 MDx Health Quest Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.1.5 MDx Health Quest Diagnostics Recent Development
11.2 R-Biopharm AG
11.2.1 R-Biopharm AG Company Details
11.2.2 R-Biopharm AG Business Overview
11.2.3 R-Biopharm AG In-Vitro Cancer Diagnostics Introduction
11.2.4 R-Biopharm AG Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.2.5 R-Biopharm AG Recent Development
11.3 Signature Diagnostics
11.3.1 Signature Diagnostics Company Details
11.3.2 Signature Diagnostics Business Overview
11.3.3 Signature Diagnostics In-Vitro Cancer Diagnostics Introduction
11.3.4 Signature Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.3.5 Signature Diagnostics Recent Development
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Company Details
11.4.2 Siemens Healthcare Business Overview
11.4.3 Siemens Healthcare In-Vitro Cancer Diagnostics Introduction
11.4.4 Siemens Healthcare Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.4.5 Siemens Healthcare Recent Development
11.5 Randox Laboratories
11.5.1 Randox Laboratories Company Details
11.5.2 Randox Laboratories Business Overview
11.5.3 Randox Laboratories In-Vitro Cancer Diagnostics Introduction
11.5.4 Randox Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.5.5 Randox Laboratories Recent Development
11.6 Epigenomics AG
11.6.1 Epigenomics AG Company Details
11.6.2 Epigenomics AG Business Overview
11.6.3 Epigenomics AG In-Vitro Cancer Diagnostics Introduction
11.6.4 Epigenomics AG Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.6.5 Epigenomics AG Recent Development
11.7 Beckman Coulter
11.7.1 Beckman Coulter Company Details
11.7.2 Beckman Coulter Business Overview
11.7.3 Beckman Coulter In-Vitro Cancer Diagnostics Introduction
11.7.4 Beckman Coulter Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.7.5 Beckman Coulter Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories In-Vitro Cancer Diagnostics Introduction
11.8.4 Abbott Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.8.5 Abbott Laboratories Recent Development
11.9 Burning Rock
11.9.1 Burning Rock Company Details
11.9.2 Burning Rock Business Overview
11.9.3 Burning Rock In-Vitro Cancer Diagnostics Introduction
11.9.4 Burning Rock Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.9.5 Burning Rock Recent Development
11.10 Novogene
11.10.1 Novogene Company Details
11.10.2 Novogene Business Overview
11.10.3 Novogene In-Vitro Cancer Diagnostics Introduction
11.10.4 Novogene Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.10.5 Novogene Recent Development
11.11 Geneseeq
11.11.1 Geneseeq Company Details
11.11.2 Geneseeq Business Overview
11.11.3 Geneseeq In-Vitro Cancer Diagnostics Introduction
11.11.4 Geneseeq Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.11.5 Geneseeq Recent Development
11.12 Amoy Diagnostics Co.,Ltd.
11.12.1 Amoy Diagnostics Co.,Ltd. Company Details
11.12.2 Amoy Diagnostics Co.,Ltd. Business Overview
11.12.3 Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Introduction
11.12.4 Amoy Diagnostics Co.,Ltd. Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.12.5 Amoy Diagnostics Co.,Ltd. Recent Development
11.13 Daan Gene
11.13.1 Daan Gene Company Details
11.13.2 Daan Gene Business Overview
11.13.3 Daan Gene In-Vitro Cancer Diagnostics Introduction
11.13.4 Daan Gene Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.13.5 Daan Gene Recent Development
11.14 Fosun Pharma
11.14.1 Fosun Pharma Company Details
11.14.2 Fosun Pharma Business Overview
11.14.3 Fosun Pharma In-Vitro Cancer Diagnostics Introduction
11.14.4 Fosun Pharma Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.14.5 Fosun Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global In-Vitro Cancer Diagnostics Market Size, Status and Forecast 2022
List of TablesTable 1. Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Instruments
Table 3. Key Players of Reagents and Kits
Table 4. Global In-Vitro Cancer Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global In-Vitro Cancer Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global In-Vitro Cancer Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global In-Vitro Cancer Diagnostics Market Share by Regions (2016-2021)
Table 8. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global In-Vitro Cancer Diagnostics Market Share by Regions (2022-2027)
Table 10. In-Vitro Cancer Diagnostics Market Trends
Table 11. In-Vitro Cancer Diagnostics Market Drivers
Table 12. In-Vitro Cancer Diagnostics Market Challenges
Table 13. In-Vitro Cancer Diagnostics Market Restraints
Table 14. Global In-Vitro Cancer Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global In-Vitro Cancer Diagnostics Market Share by Players (2016-2021)
Table 16. Global Top In-Vitro Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-Vitro Cancer Diagnostics as of 2020)
Table 17. Ranking of Global Top In-Vitro Cancer Diagnostics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by In-Vitro Cancer Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players In-Vitro Cancer Diagnostics Product Solution and Service
Table 21. Date of Enter into In-Vitro Cancer Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Table 25. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global In-Vitro Cancer Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global In-Vitro Cancer Diagnostics Revenue Market Share by Application (2016-2021)
Table 29. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global In-Vitro Cancer Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America In-Vitro Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America In-Vitro Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe In-Vitro Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe In-Vitro Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America In-Vitro Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America In-Vitro Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 61. MDx Health Quest Diagnostics Company Details
Table 62. MDx Health Quest Diagnostics Business Overview
Table 63. MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Product
Table 64. MDx Health Quest Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 65. MDx Health Quest Diagnostics Recent Development
Table 66. R-Biopharm AG Company Details
Table 67. R-Biopharm AG Business Overview
Table 68. R-Biopharm AG In-Vitro Cancer Diagnostics Product
Table 69. R-Biopharm AG Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 70. R-Biopharm AG Recent Development
Table 71. Signature Diagnostics Company Details
Table 72. Signature Diagnostics Business Overview
Table 73. Signature Diagnostics In-Vitro Cancer Diagnostics Product
Table 74. Signature Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 75. Signature Diagnostics Recent Development
Table 76. Siemens Healthcare Company Details
Table 77. Siemens Healthcare Business Overview
Table 78. Siemens Healthcare In-Vitro Cancer Diagnostics Product
Table 79. Siemens Healthcare Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 80. Siemens Healthcare Recent Development
Table 81. Randox Laboratories Company Details
Table 82. Randox Laboratories Business Overview
Table 83. Randox Laboratories In-Vitro Cancer Diagnostics Product
Table 84. Randox Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 85. Randox Laboratories Recent Development
Table 86. Epigenomics AG Company Details
Table 87. Epigenomics AG Business Overview
Table 88. Epigenomics AG In-Vitro Cancer Diagnostics Product
Table 89. Epigenomics AG Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 90. Epigenomics AG Recent Development
Table 91. Beckman Coulter Company Details
Table 92. Beckman Coulter Business Overview
Table 93. Beckman Coulter In-Vitro Cancer Diagnostics Product
Table 94. Beckman Coulter Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 95. Beckman Coulter Recent Development
Table 96. Abbott Laboratories Company Details
Table 97. Abbott Laboratories Business Overview
Table 98. Abbott Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 99. Abbott Laboratories Recent Development
Table 100. Burning Rock Company Details
Table 101. Burning Rock Business Overview
Table 102. Burning Rock In-Vitro Cancer Diagnostics Product
Table 103. Burning Rock Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 104. Burning Rock Recent Development
Table 105. Novogene Company Details
Table 106. Novogene Business Overview
Table 107. Novogene In-Vitro Cancer Diagnostics Product
Table 108. Novogene Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 109. Novogene Recent Development
Table 110. Geneseeq Company Details
Table 111. Geneseeq Business Overview
Table 112. Geneseeq In-Vitro Cancer Diagnostics Product
Table 113. Geneseeq Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 114. Geneseeq Recent Development
Table 115. Amoy Diagnostics Co.,Ltd. Company Details
Table 116. Amoy Diagnostics Co.,Ltd. Business Overview
Table 117. Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Product
Table 118. Amoy Diagnostics Co.,Ltd. Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 119. Amoy Diagnostics Co.,Ltd. Recent Development
Table 120. Daan Gene Company Details
Table 121. Daan Gene Business Overview
Table 122. Daan Gene In-Vitro Cancer Diagnostics Product
Table 123. Daan Gene Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 124. Daan Gene Recent Development
Table 125. Fosun Pharma Company Details
Table 126. Fosun Pharma Business Overview
Table 127. Fosun Pharma In-Vitro Cancer Diagnostics Product
Table 128. Fosun Pharma Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 129. Fosun Pharma Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-Vitro Cancer Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Instruments Features
Figure 3. Reagents and Kits Features
Figure 4. Global In-Vitro Cancer Diagnostics Market Share by Application: 2020 VS 2027
Figure 5. Laboratories Case Studies
Figure 6. Hospitals Case Studies
Figure 7. Others Case Studies
Figure 8. In-Vitro Cancer Diagnostics Report Years Considered
Figure 9. Global In-Vitro Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global In-Vitro Cancer Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global In-Vitro Cancer Diagnostics Market Share by Regions: 2020 VS 2027
Figure 12. Global In-Vitro Cancer Diagnostics Market Share by Regions (2022-2027)
Figure 13. Global In-Vitro Cancer Diagnostics Market Share by Players in 2020
Figure 14. Global Top In-Vitro Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-Vitro Cancer Diagnostics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by In-Vitro Cancer Diagnostics Revenue in 2020
Figure 16. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Figure 17. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2022-2027)
Figure 18. North America In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America In-Vitro Cancer Diagnostics Market Share by Type (2016-2027)
Figure 20. North America In-Vitro Cancer Diagnostics Market Share by Application (2016-2027)
Figure 21. North America In-Vitro Cancer Diagnostics Market Share by Country (2016-2027)
Figure 22. United States In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe In-Vitro Cancer Diagnostics Market Share by Type (2016-2027)
Figure 26. Europe In-Vitro Cancer Diagnostics Market Share by Application (2016-2027)
Figure 27. Europe In-Vitro Cancer Diagnostics Market Share by Country (2016-2027)
Figure 28. Germany In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific In-Vitro Cancer Diagnostics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific In-Vitro Cancer Diagnostics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific In-Vitro Cancer Diagnostics Market Share by Region (2016-2027)
Figure 38. China In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America In-Vitro Cancer Diagnostics Market Share by Type (2016-2027)
Figure 46. Latin America In-Vitro Cancer Diagnostics Market Share by Application (2016-2027)
Figure 47. Latin America In-Vitro Cancer Diagnostics Market Share by Country (2016-2027)
Figure 48. Mexico In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Country (2016-2027)
Figure 54. Turkey In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. MDx Health Quest Diagnostics Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 58. R-Biopharm AG Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 59. Signature Diagnostics Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 60. Siemens Healthcare Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 61. Randox Laboratories Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 62. Epigenomics AG Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 63. Beckman Coulter Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 64. Abbott Laboratories Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 65. Burning Rock Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 66. Novogene Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 67. Geneseeq Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 68. Amoy Diagnostics Co.,Ltd. Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 69. Daan Gene Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 70. Fosun Pharma Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Keyplayers in Global In-Vitro Cancer Diagnostics Market Size, Status and Forecast 2022
MDx Health Quest DiagnosticsR-Biopharm AG
Signature Diagnostics
Siemens Healthcare
Randox Laboratories
Epigenomics AG
Beckman Coulter
Abbott Laboratories
Burning Rock
Novogene
Geneseeq
Amoy Diagnostics Co.,Ltd.
Daan Gene
Fosun Pharma